glp-1 and parkinson's disease disease(PD)is pathologically characterized by abnormal accumulation of α-synuclein fibers(Lewy bodies) in the substantia nigra other brain regions.🧠Triple-hit hypothesis of gut microbiota in PD.(Blue pathway)👉🏻First,Akkermansia,which Role of glucagon-like peptide-1 receptor

N., Hess, S., Klemm, P., Burgeno, L

2022, Garvey et al

Vrang N, Jelsing J, Simonsen L, Jensen AE, Thorup I, Soeborg H, and Knudsen LB

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)

( 10.1111/dom.14174) [DOI] [PMC free article] [PubMed] [Google Scholar] Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, et al

Similarly to how you began your GLP-1 protocol by titrating from a conservative dose up to an amount that is uniquely therapeutic for you, you should also gradually ramp up your fiber intake especially if you dont get much or any from your standard diet